- Home
- BOF vs PASG Comparison
BOF vs PASG Comparison
Compare BOF & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- PASG
- Stock Information
- Founded
- BOF 2017
- PASG 2017
- Country
- BOF United States
- PASG United States
- Employees
- BOF N/A
- PASG N/A
- Industry
- BOF Packaged Foods
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- PASG Health Care
- Exchange
- BOF Nasdaq
- PASG Nasdaq
- Market Cap
- BOF 33.2M
- PASG 27.6M
- IPO Year
- BOF 2023
- PASG 2020
- Fundamental
- Price
- BOF $3.00
- PASG $8.93
- Analyst Decision
- BOF
- PASG Strong Buy
- Analyst Count
- BOF 0
- PASG 4
- Target Price
- BOF N/A
- PASG $34.50
- AVG Volume (30 Days)
- BOF 182.7K
- PASG 41.6K
- Earning Date
- BOF 11-12-2025
- PASG 11-10-2025
- Dividend Yield
- BOF N/A
- PASG N/A
- EPS Growth
- BOF N/A
- PASG N/A
- EPS
- BOF N/A
- PASG N/A
- Revenue
- BOF $11,218,127.00
- PASG N/A
- Revenue This Year
- BOF N/A
- PASG N/A
- Revenue Next Year
- BOF N/A
- PASG N/A
- P/E Ratio
- BOF N/A
- PASG N/A
- Revenue Growth
- BOF 72.85
- PASG N/A
- 52 Week Low
- BOF $1.53
- PASG $5.12
- 52 Week High
- BOF $3.44
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- BOF 55.60
- PASG 55.70
- Support Level
- BOF $2.55
- PASG $7.13
- Resistance Level
- BOF $3.00
- PASG $9.12
- Average True Range (ATR)
- BOF 0.25
- PASG 0.96
- MACD
- BOF -0.05
- PASG 0.09
- Stochastic Oscillator
- BOF 48.39
- PASG 66.71
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.